• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Regeneron Pharmaceuticals (REGN)

Common Shares
Sell: $508.00|Buy: $509.00|Change: 13.82 (-2.64%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approvedfor wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Address

777 Old Saw Mill River Road
Tarrytown
NY
USA
10591-6707

Telephone

+1 914 8475126

Website

https://www.regeneron.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Regeneron Pharmaceuticals Inc Annual General Meeting for 20262026-06-12T10:30:00
Regeneron Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-04-29T08:30:00
Regeneron Pharmaceuticals Inc First Quarter Earnings Results for 20262026-04-29T00:00:00
Regeneron Pharmaceuticals Inc Annual Report for 20252026-02-05T00:00:00
Regeneron Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-04T08:30:00
Regeneron Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-02-04T00:00:00
Regeneron Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-10-31T08:30:00
Regeneron Pharmaceuticals Inc Third Quarter Earnings Results for 20252025-10-31T00:00:00
Regeneron Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-08-01T08:30:00
Regeneron Pharmaceuticals Inc Second Quarter Earnings Results for 20252025-08-01T00:00:00
Regeneron Pharmaceuticals Inc Annual General Meeting for 20252025-06-13T10:30:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-09T10:40:00

Previous key dates

NameKey Date
Regeneron Pharmaceuticals Inc Annual General Meeting for 20252025-06-13T10:30:00
Goldman Sachs 46th Annual Global Healthcare Conference2025-06-09T10:40:00
Bernstein 41st Annual Strategic Decisions Conference2025-05-28T11:00:00
2025 RBC Capital Markets Global Healthcare Conference2025-05-20T11:00:00
BofA Securities 2025 Health Care Conference2025-05-13T13:00:00
Regeneron Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-04-29T08:30:00
Regeneron Pharmaceuticals Inc First Quarter Earnings Result for 20252025-04-29T00:00:00
Leerink Partners 2025 Global Healthcare Conference2025-03-11T08:00:00
TD Cowen 45th Annual Health Care Conference2025-03-04T11:50:00
Regeneron Pharmaceuticals Inc Annual Report for 20242025-02-05T00:00:00
Regeneron Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20242025-02-04T08:30:00
Regeneron Pharmaceuticals Inc Fourth Quarter Earnings Result for 20242025-02-04T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T17:15:00
Piper Sandler 36th Annual Healthcare Conference2024-12-05T09:30:00
Jefferies London Healthcare Conference2024-11-19T06:00:00
Regeneron Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20242024-10-31T08:30:00
Regeneron Pharmaceuticals Inc Third Quarter Earnings Result for 20242024-10-31T00:00:00
European Society for Medical Oncology (ESMO) 20242024-09-16T08:30:00
Regeneron Pharmaceuticals, Inc 2024 Wells Fargo Healthcare Conference2024-09-05T12:45:00
Regeneron Pharmaceuticals, Inc Morgan Stanley 22nd Annual Global Healthcare Conference2024-09-04T11:30:00
Regeneron Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20242024-08-01T08:30:00
Regeneron Pharmaceuticals Inc Second Quarter Earnings Result for 20242024-08-01T00:00:00
Regeneron Pharmaceuticals Inc Annual General Meeting for 20242024-06-14T10:30:00
Goldman Sachs 45th Annual Global Healthcare Conference2024-06-11T08:00:00
Jefferies Global Healthcare Conference2024-06-05T08:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.